Swiss drug maker Roche has decided to pull out from its involvement in the creation of an antibiotic meant to combat superbug-related infections. The development of the experimental drug will be continued by Roche's partner Polyphor.
Swiss drug maker Roche has decided to pull out from its involvement in the creation of an antibiotic meant to combat superbug-related infections. The development of the experimental drug will be continued by Roche's partner Polyphor.
Share this Article
Recommended